Biocon Q1 Results FY26: Q1 PAT Falls 95.24% to ₹31.04 Crore; Revenue Up 14.83% YoY

Biocon Q1 Results FY26: Biocon posted its Q1 results on 7th August 2025. The company posted robust numbers, with Q1 PAT standing at ₹31.40 crores against revenue of ₹3,941.9 crores. During Q1 FY26, the profit decrease of the company was recorded at 95.24% YoY, and the revenue increase for the same period was 14.83%. 

BioconQ1 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)

(Figures in crores)

BioconQ1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

(Figures in crores)

Biocon Q1 Results FY26 Highlights (Q1 FY26 vs FY25)

• Biocon clocked Q1 FY26 consolidated revenue of ₹3,941.90 crores vs ₹3,432.90 crores. 
• On the profit front, Biocon earned a consolidated PAT of ₹31.40 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹659.70 crore. 
• Consolidated PAT fell for the first quarter of FY26, was 95.24% YoY, and revenue rose 14.83% YoY. 
• As per the standalone figures, the quarterly PAT of Biocon has decreased by 1,022.22%, and revenue has increased by 5.19% YoY.

Biocon Share Price Performance

On the opening bell of 8th August 2025, the shares of Biocon opened at ₹358.90 per share. However, the initial gains are wiped out as of now, and Biocon shares are trading at ₹356.85 per share, higher than their opening price. 

Considering the long-term performance, Biocon shares have yielded close to 5.12% returns in the past 1 year, and 5-year returns stand at -10.70%. Over the maximum timeframe, the Bioconshare provided 636.73% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in Biocon shares after thorough research. 

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Also Read : Marico Q1 Results FY26: Q1 PAT Up 8.62% to ₹504.00 Crore; Revenue Surged 23.31% YoY

Recent Articles

Best Penny Stocks for Long Term in India | Penny Stocks in 2025

Berger Paints Q1 Results FY26: Q1 PAT Narrows 11.01% to ₹314.63 Crore; Revenue Surged 3.55% YoY

Tega Industries Q1 Results FY26: Q1 PAT Falls 3.83% to ₹35.34 Crore; Revenue Jumps 4.74% YoY

Alembic Pharmaceuticals Q1 Results FY26: Q1 PAT Soars 14.60% to ₹154.38 Crore; Revenue Up 9.54% YoY

BLS International Services Q1 Results FY26: Q1 PAT Soars 49.76% to ₹171.00 Crore; Revenue Up 44.23% YoY